AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. 

Biotechnology

AlloVir

The Waltham office likely focuses on clinical, regulatory, IT, and accounting functions in the biotech and pharmaceutical sectors.

Waltham

AlloVir's headquarters in Houston, TX, United States

Ann Leen

Fiona Murray

Heather Amar

Julie

Francesca Cardarelli

Morana Jovan-Embiricos

Malcolm Brenner

Jeffrey Bornstein

John F. Dipersio

Anil Chandraker

Michael Boeckh

John W. Mellors

Stella Davies

Juan Vera

The Regulatory Affairs Team at AlloVir plays a crucial role in ensuring that the company’s innovative cell therapies meet all regulatory requirements for safety and efficacy. This team collaborates closely with research and development, clinical operations, and commercial strategy to prepare and submit proposals to regulatory agencies, navigate compliance issues, and facilitate approval processes for new therapies. Their expertise is essential for advancing AlloVir's mission of restoring immunity in patients with compromised health.

Regulatory Affairs Team

The Clinical Operations Team at AlloVir is responsible for overseeing the planning, execution, and management of clinical trials aimed at developing innovative cell therapies. They collaborate with various departments to ensure compliance with regulatory standards, monitor patient safety, and facilitate effective data collection and analysis to advance the company’s mission of restoring immunity in patients with compromised immune systems.

Clinical Operations Team

The Leadership Team at AlloVir is responsible for guiding the strategic direction and operational execution of the company’s mission to develop innovative cell therapies. This team, comprising key executives such as the CEO, Chief Scientific Officer, and CFO, collaborates to ensure alignment across research, clinical development, and commercialization efforts, while fostering a culture of scientific excellence and financial sustainability. Their collective expertise drives the advancement of therapies aimed at restoring immunity in patients facing life-threatening virus-associated diseases.

AlloVir

Org chart

Board & advisors

Teams

Regulatory Affairs Team

Clinical Operations Team

Leadership Team

Offices

AlloVir

Org chart

Board & advisors

Teams

Regulatory Affairs Team

Clinical Operations Team

Leadership Team

Offices

Related companies